REAP Financial Group’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$787K Sell
3,097
-73
-2% -$17K 0.13% 55
2026
Q1
$775K Buy
3,170
+291
+10% +$67.8K 0.15% 54
2025
Q4
$596K Buy
2,879
+526
+22% +$104K 0.12% 65
2025
Q3
$436K Buy
2,353
+177
+8% +$30.3K 0.09% 71
2025
Q2
$332K Buy
2,176
+487
+29% +$74.9K 0.08% 90
2025
Q1
$280K Buy
1,689
+302
+22% +$47.3K 0.07% 96
2024
Q4
$201K Buy
1,387
+32
+2% +$4.96K 0.05% 108
2024
Q3
$220K Buy
1,355
+156
+13% +$24.9K 0.05% 106
2024
Q2
$175K Buy
1,199
+691
+136% +$103K 0.05% 123
2024
Q1
$80.3K Sell
508
-1,223
-71% -$195K 0.02% 169
2023
Q4
$271K Buy
+1,731
New +$265K 0.08% 112

Other funds holding JNJ

REAP Financial Group's JNJ Position: Q2 2026 in Review

REAP Financial Group reduced its Johnson & Johnson (JNJ) stake by 2.3% in Q2 2026, selling an estimated $17K and leaving 3,097 shares worth $787K. The position accounts for 0.13% of the portfolio, ranked #55.

REAP Financial Group first reported a position in JNJ in Q4 2023 and has held it in 11 quarters since. 4,665 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

  • REAP Financial Group held 3,097 shares of Johnson & Johnson worth $787K as of Q2 2026.
  • REAP Financial Group sold 73 Johnson & Johnson shares in Q2 2026, an estimated $17K.
  • Johnson & Johnson made up 0.13% of REAP Financial Group's portfolio in Q2 2026, its #55 holding.
  • REAP Financial Group first reported a position in Johnson & Johnson in Q4 2023 and has held it in 11 quarters since.
  • 4,665 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on REAP Financial Group's 13F filing for Q2 2026, filed 4 Aug 2026.